Clinical Trial

Munich ME/CFS Cohort Study

Study acronym: MUC-CFS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2023 (before its estimated January 2024 completion). Its status may not reflect the trial's current state.
Summary
The Munich cohort study MUC-CFS aims at the characterization and long-term follow-up of myalgic encephalitis/chronic fatigue syndrome (ME/CFS) in young people aged up to 25 years, as well as at the identification of pathomechanisms, biomarkers, and targets for future treatment approaches.
Trial Details
NCT Number NCT06005246
Lead Sponsor Technical University of Munich
Collaborators: Helmholtz Zentrum München, German Cancer Research Center, Charité University Hospital, Berlin, Germany
Conditions Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
Enrollment 200 participants
Start Date 2019-01-22
Primary Completion 2024-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2023-08-22